A new biological framework for cancer research

Lancet

Volumn 348, Issue 9035, 1996, Pages 1149-1151

  Schipper, Harvey ^a,c   Turley, Eva A ^a   Baum, Michael ^b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ST BONIFACE GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER RESEARCH; CANCER THERAPY; CELL TRANSFORMATION; ENVIRONMENTAL FACTOR; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0030603338     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)06184-3     Document Type: Note

References (33)

1. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 1991; 62: 327-36.
2. Schipper H, Goh CR, Wang TL. Rethinking cancer: Should we control rather than kill? Part I. Can J Oncol 1993; 3: 207-16.
3. Schipper H, Goh CR, Wang TL. Rethinking cancer: should we control rather than kill? Part 2. Can J Oncol 1993; 3: 220-24.
4. Schipper H, Goh CR, Wang TL. Shifting the cancer paradigm: Must we kill to cure? J Clin Oncol 1995; 13: 801-07.
5. Israel L. Tumour progression: Random mutations or an integrated survival response to cellular stress conserved from unicellular organisms? J Theor Biol 1996; 178: 375-80.
6. Nobes CD, Hall A. Rho, rac, and cdc42 GTPases: Regulation of actin structures, cell adhesion and motility. Biochem Soc Trans 1955; 23: 456-59.
7. Hall CL, Yang B, Yangh Xet al. Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation. Cell. 8:1995;19-28.
8. Miller WHJ. Differentiation therapy of acute promyelocytic leukemia: clinical and molecular features. Cancer Invest 1996; 14: 142-50.
9. Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342: 575-77.
10. Hussell T, Isaacson PG, Crabtree JE, Spencer J. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 1993; 342: 571-74.
11. Levine MD, Liotta LA, Stracke MC. Stimulation and regulation of tumour cell motility in invasion and metastasis. EXS 1994; 74: 157-79.
12. Payne CM, Bernstein C, Bernstein H Apoptosis: overview emphasizing the role of oxidative stress. DNA damage and signal transduction pathways. Leuk Lymphoma. 19:1995;43-93.
13. Reed JC. Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. Curr Opin Oncol 1995; 7: 541-46.
14. Baum M, Badwe RA. Does surgery influence the natural history of breast cancer. In: Wise L, Johnson HJ, eds. Breast cancer: Controversies in management. Armonk, New York: Futura Publishing, 1996: 61-69.
15. Oliver RTD. Does surgery disseminate or accelerate cancer? Lancet 1995; 346: 1506-07.
16. Schipper H, Baum M, Turley EA. Breast cancer: Should we control rather than kill tumour cells? In: Calvo F, Crepin M, Magdelenat H, eds. Breast cancer: Advances in biology and therapeutics. Paris: John Libbey Eurotext, 1996: 235-43.
17. Sporn MB. The war on cancer. Lancet 1996; 347: 1377-81.
18. Schabel FMJ Concepts for systemic treatment of micrometastases. Cancer. 35:1975;15-24.
19. Goldie JH, Coldman AJ. The genetic origin of drug resistance in neoplasms: Implications for systemic therapy. Cancer Res 1984; 44: 3643-53.
20. Norton L, Simon R. Tumour size, sensitivity to therapy, and design of treatment schedules. Cancer Treat Rep 1977; 61: 1307-17.
21. Norton L, Surbone A. Principles of chemotherapy: Cytokinetics. In: Holland JF, Frei E III, Bast R Jr, Kufe D, Morton D, Weichselbaum R, eds. Cancer medicine. 3rd ed. Philadelphia: Lea and Febiger, 1993: 598-617.
22. Sherratt JA, Nowak MA. Oncogenes, anti-oncogenes and the immune response to cancer: A mathematical model. Proc R Soc Lond 1992; B: 261-71.
23. Porter A. Control, automation and computers. In: Anonymous, ed. IEE centenary lectures, 1871-1971: electrical science and engineering in the service of man. London, England: Institution of Electrical Engineers, 1971: 135-55.
24. Goldberger AL. Non-linear dynamics for clinicians: chaos theory, fractals, and complexity at the bedside. Lancet 1996; 347: 1312-14.
25. Gleick J. Chaos: making a new science. New York: Penguin, 1988.
26. Hall CL, Turley EA. Hyaluronan: RHAMM mediated cell locomotion and signalling in tumorigenesis. J NeuroOncol 1995; 26: 221-29.
27. Roskelley CD, Srebrow A, Bissell MJ. A hierarchy of ECM-mediated signalling regulates tissue specific gene expression. Curr Opin Cell Biol 1995; 7: 736-47.
28. Trosko JE Mechanisms of tumor promotion: possible role of inhibited intercellular communication. Eur J Cancer Clin Oncol. 23:1987;599-601.
29. Trosko JE, Jone C, Chang CC Inhibition of gap junctional-mediated intercellular communication in vitro by aldrin, dieldrin and toxaphene: a possible cellular mechanism for their tumor-promoting and neurotoxic events. Molec Toxicol. 1:1987;83-93.
30. Takahashi Y, Nishioka K Survival without tumor shrinkage: reevaluation of survival gain by cytostatic effect of chemotherapy. J Natl Cancer Inst. 87:1995;1262.
31. Bailar JC, Smith EM. Progress against cancer? N Engl J Med 1986; 314: 1226-32.
32. Anon. Breast cancer: have we lost our way? Lancet 1993; 341: 343-44.
33. Sporn MB. Carcinogenesis and cancer: Different perspectives on the same disease. Cancer Res 1991; 51: 6215-18.